Sorafenib IP Impurity B | CAS 2514724-45-7 - Request Quote
Sorafenib IP Impurity B
| SZ CAT No: | SZ-S012036 |
| CAS No | 2514724-45-7 |
| Mol.F. | C25H14Cl2F4N2O |
| Mol.Wt. | 505.3 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Sorafenib IP Impurity B is chemically 1,3-Bis(6-chloro-2',3'-difluoro-[1,1'-biphenyl]-3-yl)urea. Sorafenib IP Impurity B is supplied with detailed characterization data compliant with regulatory guideline. Sorafenib IP Impurity B can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sorafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2514724-45-7
Purchase 2514724-45-7
Order 2514724-45-7
Enquire 2514724-45-7
price of 2514724-45-7
2514724-45-7 Supplier
2514724-45-7 Manufacturer
2514724-45-7 Exporter
buy high quality Sorafenib IP Impurity B
Purchase Sorafenib IP Impurity B
Sorafenib IP Impurity B suppliers
Sorafenib IP Impurity B manufacturers
Sorafenib IP Impurity B price
Order Sorafenib IP Impurity B
Enquire Sorafenib IP Impurity B
Sorafenib IP Impurity B cost
Sorafenib IP Impurity B Supplier
Sorafenib IP Impurity B Distributor
Sorafenib IP Impurity B for Method Validation
Sorafenib Reference Standard
Sorafenib IP Impurity B for ANDA Filing
Sorafenib IP Impurity B for Forced Degradation Studies
Sorafenib IP Impurity B Identification Standards
Sorafenib IP Impurity B for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.